Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 000960.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -3.63 1.34 1.39
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -13.27 21.12 24.35
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.79 11.00 10.81
Cash 246.42 1.50 -0.43
Capex 56.17 -0.10 -0.22
Free Cash Flow 659.41 0.55 -0.07
Revenue -4.62 5.04 5.29
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -19.45 0.10 0.13
Operating Margin 11.63 0.06 0.05
ROA 4.70 < 0.005 < 0.005
ROE 2.37 0.02 0.02
ROIC -13.51 0.01 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 000960.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 000960.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 000960.SZ is permitted for members.